Sun Pharmaceuticals India Ltd. / Eli Lilly / Uniphos Enterprises Ltd / Cadilla Pharmaceuticals / Navkar Hybrid Seeds Pvt Ltd / Johnson and Johnson / Dr Reddy’s Laboratories Ltd / Zuari Seeds Ltd / Emcure Biotech Ltd. / Synchron Research Services Pvt Ltd. / Sun Pharmaceuticals Industries Ltd. / Green Gold Seeds Ltd / Lupin Ltd. / M.J. Pharmaceuticals / Serono S. P. A / GM / Sun Pharmaceuticals Ltd. / /
Country
Italy / Guinea / United States / Australia / China / Singapore / India / /
Event
FDA Phase / /
Facility
M/s Serum Institute of India / Plant Varieties / Serum Institute of India / All India Institute of Medical Science / National Institute of Immunology / National Institute of Virology / /
JE / Hepatitis B / r-human Hepatitis B / infection / Acute Myelogenous leukemia / /
Organization
RCGM and the Expert / M/s Serum Institute of India / Sub Committee / Indian Council of Medical Research / National Institute of Immunology / All India Institute of Medical Science / Expert / National Institute of Virology / DCGI and the Expert / Central Government / Committee on Bt / Serum Institute of India / Central / Ministry of Environment and Forests / Genetic Engineering Approval Committee / /
Decisions taken in the 62nd Meeting of the Genetic Engineering Approval Committee (GEAC) held on 13th January 2006.